Centre Georges-François Lecler

Dijon, Côte-d'Or 21079

0 studies enrolling now · 1 studies all time

What they study most

HER-2 Positive Breast Cancer, Metastatic Neoplasm

Studies at this site

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed